<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240124060802N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-07</date_registration>
      <primary_sponsor>Ghalb Al-Zahra hospital</primary_sponsor>
      <public_title>Comparison of the effect of two different modes of concurrent training on heart failure</public_title>
      <acronym>نارسایی قلبی یا Heart Failure با اختصار HF</acronym>
      <scientific_title>Comparison of the effect of two different modes of concurrent training on heart performance, biochemical and functional factors associated with sarcopenia in patients with heart failure</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-02-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75177</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Restricted randomization method with random allocation rule is used. The randomization unit is an individual that is done using a ball in a container. Also, the  allocation concealment method is used with sequentially numbered, sealed, opaque envelopes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Heart failure, Sarcopenia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: It is the concurrent training group on the same days, where a combination of resistance training and high intensity interval training are performed on the same day for 8 weeks. The resistance training protocol includes 1 to 2 sets of 10 to 15 repetitions, with a 1-minute rest between sets and a 2-minute rest between movements. Exercises with dumbbells are performed with an intensity of 50 to 65% of 1 repetition maximum, and in exercises with elastic bands, start with low resistance elastic bands (yellow) and if the person can perform the exercise in question with the rate of perceived exertion below 5 on the modified Borg scale, it also goes to colors with more resistance (red, green and blue). High intensity interval training also includes 4 repetitions of 4 minutes of exercise with an intensity of 80-90% of the peak oxygen consumption on the ergometer cycle, which are separated by 3 active rests with an intensity of 50% of the peak oxygen consumption on the cycle ergometer. Intervention 2: Intervention group: It is the concurrent training group on different days, where resistance training and high intensity interval training are performed on different for 8 weeks. The resistance training protocol includes 1 to 2 sets of 10 to 15 repetitions, with a 1-minute rest between sets and a 2-minute rest between movements. Exercises with dumbbells are performed with an intensity of 50 to 65% of 1 repetition maximum, and in exercises with elastic bands, start with low resistance elastic bands (yellow) and if the person can perform the exercise in question with the rate of perceived exertion below 5 on the modified Borg scale, it also goes to colors with more resistance (red, green and blue). High intensity interval training also includes 4 repetitions of 4 minutes of exercise with an intensity of 80-90% of the peak oxygen consumption on the ergometer cycle, which are separated by 3 active rests with an intensity of 50% of the peak oxygen consumption on the cycle ergometer. Intervention 3: Control group: The control group is that in this group, patients do not do any type of exercise for 8 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All subjects' data (non-identifiable), study protocol, statistical analysis map, informed consent form and clinical study report will be published.

When:
Access starts 6 months after results and article are published

To whom:
Researchers working in academic, scientific and medical institutions

Conditions:
In order to be used for future research

Where to obtain:
1. Zahra Karimi Ahmadabadi by email: setarekarimi374@gmail.com
Faculty of Educational Sciences and Psychology, Shiraz University
2. Dr. Javad Nemati by email: nemati_phy@yahoo.com
Faculty of Educational Sciences and Psychology, Shiraz University

How to obtain:
Correspondence by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Karimi Ahmadabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>2nd Unit Right Side, 5/12 Alley, Ahmadabad Soghad Town, Allah Sq., Modarres Blvd.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7159643447</zip>
        <telephone>+98 71 3720 6158</telephone>
        <email>zahrakarimi374@hafez.shirazu.ac.ir</email>
        <affiliation>The University of Shiraz</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Karimi Ahmadabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>2nd Unit Right Side, 5/12 Alley, Ahmadabad Soghad Town, Allah Sq., Modarres Blvd.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7159643447</zip>
        <telephone>+98 71 3720 6158</telephone>
        <email>zahrakarimi374@hafez.shirazu.ac.ir</email>
        <affiliation>The University of Shiraz</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range between 55 to 65 years
Ejection fraction equal to and less than 49
Hemodynamic stability for at least 3 months before participating in the research</inclusion_criteria>
      <agemin>55 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Infection
Pulmonary restriction
Smoking
Significant cardiac arrhythmia
Limiting or prohibiting exercise due to angina or peripheral arterial occlusive disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I50</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Heart failure</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: It is the concurrent training group on the same days, where a combination of resistance training and high intensity interval training are performed on the same day for 8 weeks. The resistance training protocol includes 1 to 2 sets of 10 to 15 repetitions, with a 1-minute rest between sets and a 2-minute rest between movements. Exercises with dumbbells are performed with an intensity of 50 to 65% of 1 repetition maximum, and in exercises with elastic bands, start with low resistance elastic bands (yellow) and if the person can perform the exercise in question with the rate of perceived exertion below 5 on the modified Borg scale, it also goes to colors with more resistance (red, green and blue). High intensity interval training also includes 4 repetitions of 4 minutes of exercise with an intensity of 80-90% of the peak oxygen consumption on the ergometer cycle, which are separated by 3 active rests with an intensity of 50% of the peak oxygen consumption on the cycle ergometer.</i_keyword>
      <i_keyword>Intervention group: It is the concurrent training group on different days, where resistance training and high intensity interval training are performed on different for 8 weeks. The resistance training protocol includes 1 to 2 sets of 10 to 15 repetitions, with a 1-minute rest between sets and a 2-minute rest between movements. Exercises with dumbbells are performed with an intensity of 50 to 65% of 1 repetition maximum, and in exercises with elastic bands, start with low resistance elastic bands (yellow) and if the person can perform the exercise in question with the rate of perceived exertion below 5 on the modified Borg scale, it also goes to colors with more resistance (red, green and blue). High intensity interval training also includes 4 repetitions of 4 minutes of exercise with an intensity of 80-90% of the peak oxygen consumption on the ergometer cycle, which are separated by 3 active rests with an intensity of 50% of the peak oxygen consumption on the cycle ergometer.</i_keyword>
      <i_keyword>Control group: The control group is that in this group, patients do not do any type of exercise for 8 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Peak oxygen consumption: In this research, peak oxygen consumption is the maximum aerobic power, which is measured by the modified Bruce test and the respiratory gas analysis device. Timepoint: Measuring peak oxygen consumption before the intervention and 48 hours after the end of the intervention. Method of measurement: Treadmill and respiratory gas analysis device.</prim_outcome>
      <prim_outcome>6-minute walking distance: In this research, 6-minute walking distance means the distance traveled in 6 minutes, which is evaluated by the 6-minute walking test. Timepoint: Measuring the distance of 6 minutes of walking before the intervention and 48 hours after the end of the intervention. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>Appendicular skeletal muscle index: In this research, appendicular skeletal muscle index refers to the mass of upper and lower body skeletal muscles in terms of height, which is measured by DEXA. Timepoint: Measuring the appendicular skeletal muscle index before the intervention and 48 hours after the end of the intervention. Method of measurement: DEXA device.</prim_outcome>
      <prim_outcome>Hand grip strength: It means the maximum hand grip strength, which is measured with a hand grip dynamometer. Timepoint: Measuring the hand grip strength before the intervention and 48 hours after the end of the intervention. Method of measurement: Handgrip device.</prim_outcome>
      <prim_outcome>Gait speed: It means the most comfortable walking speed on the 8-meter path, which is measured by recording the time. Timepoint: Measuring the gait speed before the intervention and 48 hours after the end of the intervention. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>Static balance: means the ability or lack of ability to perform the static balance test of one leg for 10 seconds. Timepoint: Measuring the static balance before the intervention and 48 hours after the end of the intervention. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>Left ventricular ejection fraction: In this study, left ventricular ejection fraction is a percentage of the end-diastolic volume that is ejected from the heart in each beat and is measured by echocardiography. Timepoint: Measurement of left ventricular ejection fraction before the intervention and 48 hours after the end of the intervention. Method of measurement: Echocardiography device.</prim_outcome>
      <prim_outcome>Fractional shortening: Fractional shortening refers to the percentage change in the dimensions of the left ventricle during systole, which is measured by echocardiography. Timepoint: Measurement of fractional shortening before the intervention and 48 hours after the end of the intervention. Method of measurement: Echocardiography device.</prim_outcome>
      <prim_outcome>C-reactive protein: It means its serum concentration, which is measured by ELISA method using a special kit. Timepoint: Measurement of C-reactive protein before the intervention and 48 hours after the end of the intervention. Method of measurement: Special kit for measuring C-reactive protein amount and required blood collection equipment.</prim_outcome>
      <prim_outcome>Testosterone: It means its serum concentration which is measured by ELISA method using a special kit. Timepoint: Testosterone measurement before the intervention and 48 hours after the end of the intervention. Method of measurement: A special kit for measuring the amount of testosterone and the necessary blood collection equipment.</prim_outcome>
      <prim_outcome>Cortisol: It means its serum concentration which is measured by ELISA method using a special kit. Timepoint: Cortisol measurement before the intervention and 48 hours after the end of the intervention. Method of measurement: A special kit for measuring the amount of cortisol and the necessary equipment for blood sampling.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>The University of Shiraz</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ghalb Al-Zahra hospital</source_name>
      <source_name>The University of Shiraz</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-11-08</approval_date>
        <contact_name>Research Ethics Committees of Faculty of Psychology and educational Sciences- Shiraz University</contact_name>
        <contact_address>2nd Unit Right Side, 5/12 Alley, Ahmadabad Soghad Town, Allah Sq., Modarres Blvd. Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
